[go: up one dir, main page]

MX2007002898A - Tableta con liberacion gastrointestinal controlada en sitio y tiempo del ingrediente activo. - Google Patents

Tableta con liberacion gastrointestinal controlada en sitio y tiempo del ingrediente activo.

Info

Publication number
MX2007002898A
MX2007002898A MX2007002898A MX2007002898A MX2007002898A MX 2007002898 A MX2007002898 A MX 2007002898A MX 2007002898 A MX2007002898 A MX 2007002898A MX 2007002898 A MX2007002898 A MX 2007002898A MX 2007002898 A MX2007002898 A MX 2007002898A
Authority
MX
Mexico
Prior art keywords
active ingredient
tablets
controlled gastrointestinal
site time
gastrointestinal release
Prior art date
Application number
MX2007002898A
Other languages
English (en)
Inventor
Achim Schaffler
Original Assignee
Nitec Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitec Pharma Ag filed Critical Nitec Pharma Ag
Priority claimed from PCT/EP2005/009726 external-priority patent/WO2006027266A1/en
Publication of MX2007002898A publication Critical patent/MX2007002898A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion describe una forma de dosis farmaceutica con liberacion gastrointestinal controlada en sitio y forma del ingrediente activo.
MX2007002898A 2004-09-10 2005-09-09 Tableta con liberacion gastrointestinal controlada en sitio y tiempo del ingrediente activo. MX2007002898A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004043863A DE102004043863A1 (de) 2004-09-10 2004-09-10 Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
US11/216,469 US20060057200A1 (en) 2004-09-10 2005-09-01 Tablets with site- and time-controlled gastrointestinal release of active ingredient
PCT/EP2005/009726 WO2006027266A1 (en) 2004-09-10 2005-09-09 Tablets with site time-controlled gastrointestinal release of active ingredient

Publications (1)

Publication Number Publication Date
MX2007002898A true MX2007002898A (es) 2007-06-15

Family

ID=35276479

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007002898A MX2007002898A (es) 2004-09-10 2005-09-09 Tableta con liberacion gastrointestinal controlada en sitio y tiempo del ingrediente activo.

Country Status (12)

Country Link
US (2) US20060057200A1 (es)
EP (1) EP2386295A3 (es)
JP (1) JP2010047607A (es)
KR (1) KR20110126757A (es)
CN (2) CN103284971B (es)
BR (1) BRPI0515345A (es)
DE (1) DE102004043863A1 (es)
IL (1) IL181680A (es)
MX (1) MX2007002898A (es)
RU (2) RU2577164C2 (es)
SG (1) SG155908A1 (es)
ZA (1) ZA200701900B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
DK1183014T3 (da) 1999-06-14 2004-02-09 Cosmo Spa Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
PL1631251T3 (pl) 2003-04-24 2011-12-30 Jagotec Ag Tabletka o opóźnionym uwalnianiu i o określonej geometrii
EP1615626B1 (en) * 2003-04-24 2009-10-14 Jagotec Ag Tablet with coloured core
JP5134955B2 (ja) * 2004-09-10 2013-01-30 ヤゴテック アクチエンゲゼルシャフト 活性成分の部位時間制御胃腸放出作用を有する錠剤
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
US8022032B2 (en) * 2004-11-19 2011-09-20 Smithkline Beecham Corporation Method for customized dispensing of variable dose drug combination products for individualizing of therapies
PT2049123E (pt) 2006-08-03 2013-03-06 Horizon Pharma Ag Tratamento de doença reumatóide com glucocorticóide de libertação retardada
EP2391369A1 (en) * 2009-01-26 2011-12-07 Nitec Pharma AG Delayed-release glucocorticoid treatment of asthma
NZ582836A (en) * 2009-01-30 2011-06-30 Nitec Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
US8945615B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945616B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
CN102218071A (zh) * 2010-04-06 2011-10-19 上海安瀚特生物医药技术有限公司 一种微粉化地夫可特口服制剂及其制备方法
WO2013030726A1 (en) * 2011-08-26 2013-03-07 Wockhardt Limited Programmed drug delivery
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
CN103690545A (zh) * 2013-11-27 2014-04-02 河南中帅医药科技股份有限公司 口服泼尼松择时释放制剂及其制备方法
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230576B (it) 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
JP2558396B2 (ja) 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
WO1994008589A1 (en) * 1992-10-09 1994-04-28 The Board Of Trustees Of The Leland Stanford Junior University Treatment of systemic lupus erythematosus with dehydroepiandrosterone
US5464633A (en) 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
HRP970493A2 (en) 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
US5792476A (en) 1996-12-19 1998-08-11 Abigo Medical Ab Sustained release glucocorticoid pharmaceutical composition
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
DK1067910T3 (da) 1998-04-03 2004-10-04 Egalet As Komposition med styret afgivelse
GB9905898D0 (en) 1999-03-15 1999-05-05 Darwin Discovery Ltd Controlled-dose formulation
JP2001010950A (ja) * 1999-06-29 2001-01-16 Taiyo Yakuhin Kogyo Kk 安定で良好な薬物放出を有する医薬組成物
EP1074249A1 (en) 1999-07-27 2001-02-07 Jagotec Ag A pharmaceutical tablet system for releasing at least one active substance during a release period subsequent to a no-release period
DE10012555A1 (de) * 2000-03-15 2001-09-20 Merck Patent Gmbh Glucocorticoide in einer Modified Release-Formulierung
US20020028240A1 (en) * 2000-04-17 2002-03-07 Toyohiro Sawada Timed-release compression-coated solid composition for oral administration
AU2001247887A1 (en) 2000-04-19 2001-11-07 Eurand America Inc. Dual mechanism timed release dosage forms for low dose drugs
US6620439B1 (en) 2000-10-03 2003-09-16 Atul M. Mehta Chrono delivery formulations and method of use thereof
ES2436523T3 (es) 2001-03-13 2014-01-02 Endo Pharmaceuticals Inc. Formas de dosificación terapéutica
WO2003075919A1 (fr) * 2002-03-14 2003-09-18 Daiichi Suntory Pharma Co.,Ltd. Comprime contenant du chlorhydrate de pilsicainide (voie seche)
PL1631251T3 (pl) 2003-04-24 2011-12-30 Jagotec Ag Tabletka o opóźnionym uwalnianiu i o określonej geometrii
EP1615626B1 (en) * 2003-04-24 2009-10-14 Jagotec Ag Tablet with coloured core
AU2004273958A1 (en) * 2003-09-19 2005-03-31 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
JP5134955B2 (ja) * 2004-09-10 2013-01-30 ヤゴテック アクチエンゲゼルシャフト 活性成分の部位時間制御胃腸放出作用を有する錠剤
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum

Also Published As

Publication number Publication date
KR20110126757A (ko) 2011-11-23
CN103284971A (zh) 2013-09-11
DE102004043863A1 (de) 2006-03-16
BRPI0515345A (pt) 2008-07-22
RU2435568C2 (ru) 2011-12-10
US20060057200A1 (en) 2006-03-16
RU2577164C2 (ru) 2016-03-10
CN103284971B (zh) 2016-05-11
ZA200701900B (en) 2008-07-30
HK1110509A1 (en) 2008-07-18
RU2007113168A (ru) 2008-10-27
US20120213910A1 (en) 2012-08-23
EP2386295A3 (en) 2012-04-25
CN101035517A (zh) 2007-09-12
CN101035517B (zh) 2013-03-13
IL181680A0 (en) 2007-07-04
JP2010047607A (ja) 2010-03-04
HK1189346A1 (zh) 2014-06-06
EP2386295A2 (en) 2011-11-16
SG155908A1 (en) 2009-10-29
IL181680A (en) 2015-04-30
RU2011119347A (ru) 2012-11-20

Similar Documents

Publication Publication Date Title
IL181680A0 (en) Tablets with site time -controlled gastrointestinal release of active ingredient
JP2007504142A5 (ja) Ｈｉｖプロテアーゼ阻害薬固体分散物を含む固体薬物剤形
PL373914A1 (en) Immediate release dosage forms containing solid drug dispersions
PH12012501811A1 (en) A solid pharmaceutical dosage formulation
TWI366460B (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
IL191804A0 (en) Solid dispersion containing an active ingredient and tablets for oral administration containing the same
WO2006014973A3 (en) Pharmaceutical dosage forms including rasagiline
IL188744A0 (en) High drug load formulations and dosage forms
NO20071806L (no) Tabletter med steds- og tidsregulert gastrointestinal frigivelse av aktiv bestanddel.
MX2010007083A (es) Combinacion anti-retroviral.
ZA200605631B (en) Directly compressible pharmaceutical composition for the oral administration of CCI-779
ZA200709788B (en) Cannabinold active pharmaceutical ingredient for Improved dosage forms
WO2007001888A3 (en) New regimens for controlled drug delivery devices for contraception
IL184067A0 (en) Tablet formulation for sustained drug-release
ZA200701443B (en) Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle
ITMI20011338A0 (it) Composizioni farmaceutiche orali a rilascio immediato del principio attivo
WO2007141743A3 (en) A tablet dosage form comprising cetirizine and pseudoephedrine
IL178067A0 (en) Pharmaceutical dosage forms and compositions
EP1900368A4 (en) TABLET WITH A SPIRIT OF SOLUBLE ACTIVE SUBSTANCE
EP1731609A4 (en) INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF
IS7383A (is) Skammtaform með stýrða lyflosun til inngjafar
JO3239B1 (ar) تركيبات جالينية من مركبات عضوية
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
TW200744610A (en) New regimens for controlled drug delivery devices for contraception

Legal Events

Date Code Title Description
GB Transfer or rights
FG Grant or registration